Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ethan Hollingsworth, Jamil Khouri & Jaime Imitola. (2017) Endogenous repair and development inspired therapy of neurodegeneration in progressive multiple sclerosis. Expert Review of Neurotherapeutics 17:6, pages 611-629.
Read now
Read now
Articles from other publishers (48)
Ana Maria Buga, Vlad Padureanu, Anca-Lelia Riza, Carmen Nicoleta Oancea, Carmen Valeria Albu & Alexandru Dan Nica. (2023) The Gut–Brain Axis as a Therapeutic Target in Multiple Sclerosis. Cells 12:14, pages 1872.
Crossref
Crossref
Marianna G. Rispoli, Maria D’Apolito, Valeria Pozzilli & Valentina Tomassini. 2023. Precision Medicine in Neurodegenerative Disorders, Part II. Precision Medicine in Neurodegenerative Disorders, Part II
293
311
.
Fereshteh Ghadiri, Zahra Ebadi, Elnaz Asadollahzadeh & Abdorreza Naser Moghadasi. (2022) Gut microbiome in multiple sclerosis-related cognitive impairment. Multiple Sclerosis and Related Disorders 67, pages 104165.
Crossref
Crossref
I. S. Kiselev, O. G. Kulakova, L. V. Danilova, O. A. Baturina, M. R. Kabilov, E. V. Popova, A. N. Boyko & O. O. Favorova. (2022) Genome-Wide Analysis of DNA Methylation in Cd4+ T Lymphocytes of Patients with Primary Progressive Multiple Sclerosis Indicates Involvement of This Epigenetic Process in the Disease Immunopathogenesis. Molecular Biology 56:3, pages 417-423.
Crossref
Crossref
Ivan Kiselev, Ludmila Danilova, Natalia Baulina, Olga Baturina, Marsel Kabilov, Alexey Boyko, Olga Kulakova & Olga Favorova. (2022) Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis patients. Multiple Sclerosis and Related Disorders 60, pages 103714.
Crossref
Crossref
Parnian Shobeiri, Amirali Kalantari, Antônio L. Teixeira & Nima Rezaei. (2022) Shedding light on biological sex differences and microbiota–gut–brain axis: a comprehensive review of its roles in neuropsychiatric disorders. Biology of Sex Differences 13:1.
Crossref
Crossref
Shokufeh Ghasemian Sorboni, Hanieh Shakeri Moghaddam, Reza Jafarzadeh-Esfehani & Saman Soleimanpour. (2022) A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clinical Microbiology Reviews 35:1.
Crossref
Crossref
Divya Goyal, Mangaldeep Dey & Rakesh Kumar Singh. 2022. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases
33
68
.
Izhak Levi, Michael Gurevich, Gal Perlman, David Magalashvili, Shay Menascu, Noam Bar, Anastasia Godneva, Liron Zahavi, Danyel Chermon, Noa Kosower, Bat Chen Wolf, Gal Malka, Maya Lotan-Pompan, Adina Weinberger, Erez Yirmiya, Daphna Rothschild, Sigal Leviatan, Avishag Tsur, Maria Didkin, Sapir Dreyer, Hen Eizikovitz, Yamit Titngi, Sue Mayost, Polina Sonis, Mark Dolev, Yael Stern, Anat Achiron & Eran Segal. (2021) Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis. Cell Reports Medicine 2:4, pages 100246.
Crossref
Crossref
Concetta Scazzone, Luisa Agnello, Giulia Bivona, Bruna Lo Sasso & Marcello Ciaccio. (2020) Vitamin D and Genetic Susceptibility to Multiple Sclerosis. Biochemical Genetics 59:1, pages 1-30.
Crossref
Crossref
Natalia Baulina, Ivan Kiselev & Olga Favorova. (2021) Imprinted Genes and Multiple Sclerosis: What Do We Know?. International Journal of Molecular Sciences 22:3, pages 1346.
Crossref
Crossref
Meng-Han Shen, Chau Yee Ng, Kuo-Hsuan Chang & Ching-Chi Chi. (2020) Association of multiple sclerosis with vitiligo: a systematic review and meta-analysis. Scientific Reports 10:1.
Crossref
Crossref
I. S. Kiselev, M. S. Kozin, N. M. Baulina, G. V. Pavlova, A. N. Boyko, O. G. Kulakova & O. O. Favorova. (2020) Polymorphic variants in the PVT1 locus affect multiple sclerosis severity. Neurology, Neuropsychiatry, Psychosomatics 12:1S, pages 4-8.
Crossref
Crossref
Elia Gil‐Varea, Nino Spataro, Luisa María Villar, Amalia Tejeda‐Velarde, Luciana Midaglia, Fuencisla Matesanz, Sunny Malhotra, Herena Eixarch, Nikolaos Patsopoulos, Óscar Fernández, Begoña Oliver‐Martos, Albert Saiz, Sara Llufriu, Lluís Ramió‐Torrentà, Ester Quintana, Guillermo Izquierdo, Antonio Alcina, Elena Bosch, Arcadi Navarro, Xavier Montalban & Manuel Comabella. (2020) Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genes. Human Mutation 41:7, pages 1308-1320.
Crossref
Crossref
Athanasios Metaxakis, Dionysia Petratou & Nektarios Tavernarakis. (2020) Molecular Interventions towards Multiple Sclerosis Treatment. Brain Sciences 10:5, pages 299.
Crossref
Crossref
Giovanni Schepici, Serena Silvestro, Placido Bramanti & Emanuela Mazzon. (2019) The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials. Cell Transplantation 28:12, pages 1507-1527.
Crossref
Crossref
I. S. Kiselev, O. G. Kulakova, N. M. Baulina, V. V. Bashinskaya, E. V. Popova, A. N. Boyko & O. O. Favorova. (2019) Variability of the MIR196A2 Gene as a Risk Factor in Primary-Progressive Multiple Sclerosis Development. Molecular Biology 53:2, pages 249-255.
Crossref
Crossref
M. S. Kozin, O. G. Kulakova & O. O. Favorova. (2018) Involvement of Mitochondria in Neurodegeneration in Multiple Sclerosis. Biochemistry (Moscow) 83:7, pages 813-830.
Crossref
Crossref
E. V. Popova, I. S. Kiselev, A. N. Boiko, S. A. Sivertseva, N. A. Malkova, D. S. Korobko, N. N. Spirin, D. S. Kasatkin, A. V. Karaeva, E. L. Turova, N. N. Spirina, L. I. Volkova, N. M. Baulina, V. V. Bashinskaya, O. G. Kulakova & O. O. Favorova. (2018) Polymorphic Variants of Immune Response Genes as a Risk Factor for the Development of Primary Progressive Multiple Sclerosis. Neuroscience and Behavioral Physiology 48:6, pages 661-667.
Crossref
Crossref
Madison R. Hansen & Darin T. Okuda. (2018) Precision medicine for multiple sclerosis promotes preventative medicine. Annals of the New York Academy of Sciences 1420:1, pages 62-71.
Crossref
Crossref
Koen Vandenbroeck. (2017) The era of GWAS is over – Yes. Multiple Sclerosis Journal 24:3, pages 256-257.
Crossref
Crossref
Andrea Latini, Cinzia Ciccacci, Giuseppe Novelli & Paola Borgiani. (2017) Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility. Immunologic Research 65:4, pages 811-827.
Crossref
Crossref
Mahsa Khayat-Khoei, Leorah Freeman & John Lincoln. 2017. Nanomedicine for Inflammatory Diseases. Nanomedicine for Inflammatory Diseases
171
192
.
Iris Grossman, Volker Knappertz, Daphna Laifenfeld, Colin Ross, Ben Zeskind, Sarah Kolitz, David Ladkani, Liat Hayardeny, Pippa Loupe, Ralph Laufer & Michael Hayden. (2017) Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research. Progress in Neurobiology 152, pages 114-130.
Crossref
Crossref
Wen‑Juan Huang, Wei‑Wei Chen & Xia Zhang. (2017) Multiple sclerosis: Pathology, diagnosis and treatments (Review). Experimental and Therapeutic Medicine.
Crossref
Crossref
Ann E. Slingerland, Zaker Schwabkey, Diana H. Wiesnoski & Robert R. Jenq. (2017) Clinical Evidence for the Microbiome in Inflammatory Diseases. Frontiers in Immunology 8.
Crossref
Crossref
Giuseppe Migliara, Martin Mueller, Alessia Piermattei, Chaya Brodie, Michael J. Paidas, Eytan R. Barnea & Francesco Ria. (2017)
PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis
M.smegmatis
model
. Oncotarget 8:13, pages 21834-21851.
Crossref
Crossref
Juan Jovel, Sandra O'keefe, Jordan Patterson, Michael Bording-Jorgensen, Weiwei Wang, Andrew L. Mason, Kenneth G. Warren & Gane Ka-Shu Wong. (2017) Cerebrospinal Fluid in a Small Cohort of Patients with Multiple Sclerosis Was Generally Free of Microbial DNA. Frontiers in Cellular and Infection Microbiology 6.
Crossref
Crossref
E. V. Popova, I. S. Kiselev, A. N. Boyko, S. A. Sivertseva, N. A. Malkova, D. S. Korobko, N. N. Spirin, D. S. Kasatkin, A. V. Karaeva, E. L. Turova, N. N. Spirina, L. I. Volkova, N. M. Baulina, V. V. Bashinskaya, O. G. Kulakova & O. O. Favorova. (2017) Polymorphic variants of the immune response genes as risk factors for primary progressive multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:2. Vyp. 2, pages 14.
Crossref
Crossref
A. Dessa Sadovnick. 2017. Health Issues in Women with Multiple Sclerosis. Health Issues in Women with Multiple Sclerosis
1
8
.
Jun Chen, Nicholas Chia, Krishna R. Kalari, Janet Z. Yao, Martina Novotna, M. Mateo Paz Soldan, David H. Luckey, Eric V. Marietta, Patricio R. Jeraldo, Xianfeng Chen, Brian G. Weinshenker, Moses Rodriguez, Orhun H. Kantarci, Heidi Nelson, Joseph A. Murray & Ashutosh K. Mangalam. (2016) Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Scientific Reports 6:1.
Crossref
Crossref
Peter Ludewig, Mattia Gallizioli, Xabier Urra, Sarah Behr, Vanessa H. Brait, Mathias Gelderblom, Tim Magnus & Anna M. Planas. (2016) Dendritic cells in brain diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:3, pages 352-367.
Crossref
Crossref
Jaime ToroDavid Cuellar-GiraldoCamilo Díaz-CruzLisseth-Estefania BurbanoClaudia-Marcela GuíoSaúl ReyesFabián CortesSimón Cárdenas-RobledoDiana M. NarváezWilmer CárdenasAlexandra PorrasMaría-Claudia LattigHelena Groot de Restrepo. (2016) HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population. Neurology Neuroimmunology & Neuroinflammation 3:1.
Crossref
Crossref
Santiago Fernández-Menéndez, Marta Fernández-Morán, Iván Fernández-Vega, Angel Pérez-Álvarez & Javier Villafani-Echazú. (2016) Epstein–Barr virus and multiple sclerosis. From evidence to therapeutic strategies. Journal of the Neurological Sciences 361, pages 213-219.
Crossref
Crossref
V. V. Bashinskaya, O. G. Kulakova, A. N. Boyko, A. V. Favorov & O. O. Favorova. (2015) A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches. Human Genetics 134:11-12, pages 1143-1162.
Crossref
Crossref
Alessandro Didonna, Noriko Isobe, Stacy J. Caillier, Kathy H. Li, Alma L. Burlingame, Stephen L. Hauser, Sergio E. Baranzini, Nikolaos A. Patsopoulos & Jorge R. Oksenberg. (2015) A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome. Human Molecular Genetics, pages ddv412.
Crossref
Crossref
Dusanka S. Skundric, William W. Cruikshank, Paul C. Montgomery, Robert P. Lisak & Harley Y. Tse. (2015) Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis. Cytokine 75:2, pages 234-248.
Crossref
Crossref
Ivan Kiselev, Vitalina Bashinskaya, Olga Kulakova, Natalia Baulina, Ekaterina Popova, Alexey Boyko & Olga Favorova. (2015) Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity. International Journal of Molecular Sciences 16:8, pages 20067-20081.
Crossref
Crossref
V.V. Bashinskaya, O.G. Kulakova, I.S. Kiselev, N.M. Baulina, A.V. Favorov, A.N. Boyko, E.Yu. Tsareva & O.O. Favorova. (2015) GWAS-identified multiple sclerosis risk loci involved in immune response: Validation in Russians. Journal of Neuroimmunology 282, pages 85-91.
Crossref
Crossref
C. Sundal, M. Baker, V. Karrenbauer, M. Gustavsen, S. Bedri, A. Glaser, K.-M. Myhr, K. Haugarvoll, H. Zetterberg, H. Harbo, I. Kockum, J. Hillert, Z. Wszolek, R. Rademakers & O. Andersen. (2015) Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. European Journal of Neurology 22:2, pages 328-333.
Crossref
Crossref
Thais F. C. Fraga-Silva, Luiza A. N. Mimura, Camila M. Marchetti, Fernanda Chiuso-Minicucci, Thais G. D. França, Sofia F. G. Zorzella-Pezavento, James Venturini, Maria S. P. Arruda & Alexandrina Sartori. (2015)
Experimental Autoimmune Encephalomyelitis Development Is Aggravated by
Candida albicans
Infection
. Journal of Immunology Research 2015, pages 1-11.
Crossref
Crossref
Marek Jutel, Paweł Gonerko, Ewa Cichocka-Jarosz & Bolesław Samoliński. (2015) Stanowisko Sekcji Immunoterapii Polskiego Towarzystwa Alergologicznego w sprawie prowadzenia alergenowo swoistej immunoterapii (AIT) u pacjentów zagrożonych wystąpieniem lub z rozpoznanymi chorobami na tle autoimmunizacji. Alergologia Polska - Polish Journal of Allergology 2:1, pages 28-36.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2015. Textbook of Personalized Medicine. Textbook of Personalized Medicine
409
460
.
Kewal K. Jain. 2015. Applied Neurogenomics. Applied Neurogenomics
137
153
.
Kewal K. Jain. 2015. Applied Neurogenomics. Applied Neurogenomics
1
59
.
Jessica Bailey, Margaret Pericak-Vance & Jonathan Haines. (2014) The Impact of the Human Genome Project on Complex Disease. Genes 5:3, pages 518-535.
Crossref
Crossref
O. O. Favorova, V. V. Bashinskaya, O. G. Kulakova, A. V. Favorov & A. N. Boyko. (2014) Genome-wide association study as a method to analyze the genome architecture in polygenic diseases, with the example of multiple sclerosis. Molecular Biology 48:4, pages 496-507.
Crossref
Crossref
F.J. Dowd. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.